AS-IP Tech (OTC:IPTK) Stock, Quote.Headers.trade-ideas

AS-IP Tech Inc is engaged in creating in-flight connectivity systems that utilize Bluetooth Smart technology as a low-cost alternative to the traditionally expensive Wi-Fi platform. The company's technology consists of two products BizjetMobile and fflya. BizjetMobile provides corporate jets with an alternative global inflight connectivity solution and is marketed under the brand names CHiiMP and BizjetInternet. These are mobile apps that deliver optimized inflight text and email for passengers and crew; and fflya provides airlines with an inflight connectivity approach based on the latest mobile app technology, narrowband satellite links, and BlueTooth technology. The fflya platform reduces the installation, certification and equipment costs by up to 90% compared to inflight broadband.

AS-IP Tech Inc

<a href="https://www.globenewswire.com/Tracker?data=9txYGzddj5XqmkcafzxA8gN1tMoQQDSUNEVs8NM94vL9xd-NLcHOgSNon4qsstt91oexNNWCY_yUOlGuL7rPTA==">RenovoRx, Inc</a>. ("RenovoRx" or the "Company") (NASDAQ:<a href="https://www.benzinga.com/stock/RNXT#NASDAQ">RNXT</a>), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced that Ripal Gandhi, M.D., FSIR, FSVM will present at the Symposium on Clinical Interventional Oncology ("CIO") which is being held September 20-22, 2024, at the Loews Hotel in Miami Beach, Florida. Dr. Gandhi's presentation will highlight RenovoRx's TAMP (Trans-Arterial Micro-Perfusion) therapy platform for the treatment of locally advanced pancreatic cancer ("LAPC") and recent publications of clinical data.
Dr. Gandhi, professor of Interventional Radiology at the Miami Cancer Institute and Miami Cardiac and Vascular Institute, Florida International University Herbert Wertheim College of Medicine, is a Course Director for the Symposium on CIO. Since 2018, Dr. Gandhi has been instrumental as a principal investigator for the Miami Cancer Institute in RenovoRx's pivotal ongoing Phase III TIGeR-PaC clinical trial in LAPC.
Dr. Gandhi's presentation will&nbsp;provide an overview of the clinical challenges of the standard of care treatment available to LAPC patients. Systemic (intravenous) chemotherapy, while considered the standard-of-care for LAPC, is often associated with debilitating side effects, and may have limited effectiveness in treating this type of cancer due to tumors lacking dedicated blood vessels critical for delivering chemotherapy. Dr. Gandhi will highlight the TAMP therapy platform and the opportunity it may give to LAPC patients as a potential targeted oncology option for treatment.
Dr. Gandhi will also discuss the status of the Company's ongoing Phase III TIGeR-PaC study, which is evaluating the use of the TAMP therapy platform with gemcitabine HCl in patients with LAPC. Additionally, he will review a recent publication in the international peer-reviewed journal, The Oncologist&#xAE;, of early-stage clinical data on the intra-arterial administration of gemcitabine HCl utilizing the TAMP including Phase I/II dose escalation safety study (RR1) and acquired data from a post-marketing post-treatment observational registry study (RR2).

Biotech

News

General

RNXT

RenovoRx Announces Presentation At Symposium On Clinical Interventional Oncology Highlighting TAMP For Targeted Treatment Of Locally Advanced Pancreatic Cancer On Saturday, September 21, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5e60ff475f2b9b000113c537/adam-maeder">Piper Sandler analyst Adam Maeder</a> initiated coverage on Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) with an Overweight rating and announced a price target of $131. Abbott shares fell 2.8% to close at $114.88 on Wednesday. <a href="https://www.benzinga.com/quote/ABT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Roth MKM analyst Scott Fortune initiated coverage on Turning Point Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPB#NYSE">TPB</a>) with a Buy rating and announced a price target of $50. Turning Point Brands shares gained 0.9% to close at $39.03 on Wednesday. <a href="https://www.benzinga.com/quote/TPB/analyst-ratings">See how other analysts view this stock.</a></li>
<li>R<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/641c1355c9c7840001d30a8f/james-rollyson">aymond James analyst James Rollyson</a> initiated coverage on Helix Energy Solutions Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLX#NYSE">HLX</a>) with a Strong Buy rating and announced a price target of $14. Helix Energy shares fell 1.8% to close at $9.84 on Wednesday. <a href="https://www.benzinga.com/quote/HLX/analyst-ratings">See how other analysts view this stock.</a></li>
<li>RBC Capital analyst Jonathan Atkin initiated coverage on Charter Communications, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>) with a Sector Perform rating and announced a price target of $345. Charter Communications shares gained 0.1% to close at $339.64 on Wednesday. <a href="https://www.benzinga.com/quote/CHTR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Mizuho analyst William Janela initiated coverage on Northern Oil and Gas, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOG#NYSE">NOG</a>) with an Outperform rating and announced a price target of $47. Northern Oil &amp; Gas shares rose 0.3% to close at $36.17 on Wednesday. <a href="https://www.benzinga.com/quote/NOG/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying ABT stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="512" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19083945/image-154-1024x512.png" alt="" class="wp-image-556133" style="width:656px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19083945/image-154-1024x512.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19083945/image-154-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19083945/image-154-768x384.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19083945/image-154.png 1325w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40925678/fedex-gears-up-for-q1-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-an">FedEx Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>

Initiation

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

CHTR

This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

RZLV

Watching Rezolve AI; Shares Spike Higher As Co Issues PR Applauding The Recent Announcement By Microsoft And BlackRock To Invest $30B Into AI Infrastructure

Offerings

CRMT

America's Car-Mart Prices Public Offering Of 1.7M Shares At $43 Per Share, With Option For Additional 255K Shares; Proceeds To Repay Credit Facilities And Fund Corporate Purposes

Intelligent Bio Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INBS#NASDAQ">INBS</a>) reported $730.00 thousand in sales this quarter. This is a 64.74 percent increase over sales of $443.13 thousand the same period last year.

Earnings

Intelligent Bio Solutions Inc. - Common Stock

INBS

Intelligent Bio Solutions Q4 Sales $730.00K Up From $443.13K YoY

WIIM

HOOD

Robinhood Markets shares are trading higher after Piper Sandler maintained an Overweight rating on the stock and raised its price target from $23 to $27.

SNOA

Sonoma Pharmaceuticals Receives FDA 510(k) Clearance For Microcyn Solution With Expanded Over-The-Counter Indications For Face, Eyelid, And Eyelashes

As of Sept. 19, 2024, three stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Instacart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CART#NASDAQ">CART</a>)</h3>
<ul>
<li>On Sept. 5, Cantor Fitzgerald analyst Deepak Mathivanan initiated coverage on CART with an Overweight rating and announced a price target of $45.. The company's stock gained around 19% over the past month and has a <a href="https://www.benzinga.com/quote/CART">52-week high of $42.95</a>.</li>
<li>RSI Value: 76.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>CART Price Action: Shares of Instacart gained 5.3% to close at $39.87 on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">US Foods Holding Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USFD#NYSE">USFD</a>)</h3>
<ul>
<li>On Sept. 18, Wells Fargo analyst Edward Kelly maintained US Foods with an Overweight and raised the price target from $66 to $75. The company's stock gained around 5% over the past five days and <a href="https://www.benzinga.com/quote/USFD">has a 52-week high</a> of $62.34.</li>
<li>RSI Value: 73.11</li>
<li>USFD Price Action: Shares of US Foods fell 0.4% to close at $60.91 on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">Monster Beverage Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNST#NASDAQ">MNST</a>)</h3>
<ul>
<li>On Aug. 19, Monster Beverage said its board authorized a new share repurchase program of up to $500 million of the company's outstanding common stock. As of Aug. 19, there were no authorized share repurchases remaining under the company's previously authorized buyback program. The company's stock gained around 12% over the past month and has a <a href="https://www.benzinga.com/quote/MNST">52-week high</a> of $61.22.</li>
<li>RSI Value: 71.75</li>
<li>MNST Price Action: Shares of Monster Beverage rose 2.5% to close at $52.35 on Wednesday. </li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40925678/fedex-gears-up-for-q1-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-an">FedEx Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>

Short Ideas

CART

MNST

USFD

Top 3 Defensive Stocks You May Want To Dump In September

Lennar Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) will release earnings results for its third quarter, after the closing<a href="https://www.benzinga.com/quote/LEN/earnings"> bell on Thursday, Sept. 19.</a>
Analysts expect the Miami, Florida-based company to report quarterly earnings at $3.63 per share, down from $3.87 per share in the year-ago period. Lennar projects to report revenue of $9.16 billion for the quarter, compared to $8.45 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On June 17, Lennar reported quarterly earnings of $3.38 per share, which beat the analyst consensus estimate of $3.24 per share.
Lennar shares fell 0.5% to close at $188.43 on Wednesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/TJX/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5967569b988ca8000127b8db/jay-mccanless">Wedbush analyst Jay McCanless</a> reiterated a Neutral rating with a price target of $144 on Sept. 11. This analyst has an accuracy rate of 84%.</li>
<li>Wells Fargo analyst Sam Reid maintained an Overweight rating and raised the price target from $195 to $205 on Sept. 9. This analyst has an accuracy rate of 85%.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/584feeb6ee7bf600019078df/jade-rahmani">Keefe, Bruyette &amp; Woods analyst Jade Rahmani </a>maintained an Outperform rating and boosted the price target from $183 to $230 on Sept. 4. This analyst has an accuracy rate of 77%.</li>
<li>Seaport Global analyst Kenneth Zener downgraded the stock from Buy to Neutral on Aug. 5. This analyst has an accuracy rate of 75%.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5901e8e90bd9910001e193f6/stephen-kim">Evercore ISI Group analyst Stephen Kim</a> maintained an Outperform rating and raised the price target from $237 to $240 on July 15. This analyst has an accuracy rate of 79%.</li>
</ul>
Considering buying LEN stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="520" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19023214/image-143-1024x520.png" alt="" class="wp-image-555416" style="width:632px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19023214/image-143-1024x520.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19023214/image-143-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19023214/image-143-768x390.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19023214/image-143.png 1322w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/09/40927530/coinbase-global-electronic-arts-and-2-other-stocks-executives-are-selling">Coinbase Global, Electronic Arts And 2 Other Stocks Executives Are Selling</a></li>
</ul>

Price Target

Lennar Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Oracle Corp's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) CloudWorld in Las Vegas had no shortage of artificial intelligence (AI) buzz, but investors hoping for a quick windfall might need <a href="https://www.benzinga.com/quote/ORCL/news">to temper expectations</a>.
JPMorgan analyst Tien-tsin Huang, who attended the event, noted that while Oracle's multi-cloud advancements are laying the groundwork for the future, the immediate impact on revenues is still uncertain.
"We saw numerous examples of high-value AI-driven tech services," Huang stated, highlighting the long-term potential of AI in transforming enterprise workflows. 
However, he remains cautious about the near-term outlook, adding, "Near-term demand improvement remains elusive," despite growing client interest in AI.
<h2 class="wp-block-heading">Oracle Makes A Big Move</h2>
Oracle's big move at CloudWorld was its announcement of Oracle Database (ODB) on AWS, building on similar launches with Microsoft Corp&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) Azure and Alphabet Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google Cloud.
This multi-cloud push, Huang believes, is a critical strategy for companies looking to "maximize the value of GenAI" by optimizing data across different platforms.
Read Also: <a href="https://www.benzinga.com/startups/24/09/40922366/oracles-larry-ellison-briefly-became-wealthier-than-jeff-bezos-heres-how-his-fortune-outpaced-amazon">Oracle&#8217;s Larry Ellison Briefly Became Wealthier Than Jeff Bezos. Here&#8217;s How His Fortune Outpaced Amazon&#8217;s Founder</a>
<h2 class="wp-block-heading">Yet To See Material Revenue Momentum</h2>
Yet, the short-term demand for tech services in AI remains lukewarm. "We did not sense that any have achieved material revenue momentum in the category," Huang observed, signaling that while enterprise clients are interested in AI, the financial payoff might still be a few quarters away.
<h2 class="wp-block-heading">Accenture: A Secular Winner</h2>
Long-term, Huang is optimistic about Oracle and its tech services partners, particularly Accenture PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>), which he sees "as a secular winner" in helping companies customize and optimize generative AI solutions for business processes.
As companies transition to a more interoperable, multi-cloud environment, the opportunities for AI and tech services will grow, but patience is key.
For now, investors should keep their eyes on the big picture, as the immediate AI windfall for Oracle might take some time to materialize.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/m-a/24/09/40926078/nvidia-considers-165m-octoai-acquisition-aims-to-strengthen-ai-and-cloud-dominance">Nvidia Considers $165M OctoAI Acquisition, Aims to Strengthen AI and Cloud Dominance</a></li>
</ul>
Image: Shutterstock

GOOG

GOOGL

MSFT

ORCL

Oracle CloudWorld Highlights 'AI-Driven Tech Services,' But Revenue Growth Requires Patience: Analyst

The Nasdaq 100 closed lower by around 0.5% during Wednesday's session. Investors, meanwhile, focused on some notable insider trades.
When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.
Below is a look at a few recent notable insider sales. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Alphabet</h3>
<ul>
<li>The Trade: Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) CEO Sundar Pichai <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 22,500 shares</a> at an average price of $160.63. The insider received around $3.61 million from selling those shares.</li>
<li>What's Happening: Alphabet's Google won its appeal against the European Commission&#8217;s €1.49 billion ($1.66 billion) antitrust fine for anticompetitive practices involving its online search advertising business.</li>
<li>What Alphabet Does: Alphabet is a holding company that wholly owns internet giant Google.</li>
<li>Benzinga Pro's real-time newsfeed alerted to<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1"> latest GOOG new</a>s. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="910" height="830" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19044828/image-145.png" alt="" class="wp-image-555611" style="width:716px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19044828/image-145.png 910w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19044828/image-145-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19044828/image-145-768x700.png 768w" sizes="(max-width: 910px) 100vw, 910px" /></a></figure>
<h3 class="wp-block-heading">Williams-Sonoma</h3>
<ul>
<li>The Trade: Williams-Sonoma, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) President and CEO Laura Alber <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 40,000 shares</a> at an average price of $145.27. The insider received around $5.8 million from selling those shares.</li>
<li>What's Happening: On Sept. 16, TD Cowen analyst Max Rakhlenko maintained Williams-Sonoma with a Buy and raised the price target from $150 to $160.</li>
<li>What Williams-Sonoma Does: With a retail and direct-to-consumer presence, Williams-Sonoma is a player in the $300 billion domestic home category and $450 billion international home market, focused on expanding its exposure in the B2B ($80 billion total addressable market), marketplace, and franchise areas. </li>
<li>Benzinga Pro&#8217;s charting tool helped identify the<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1"> trend in WSM stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="927" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19044933/image-146.png" alt="" class="wp-image-555616" style="width:705px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19044933/image-146.png 927w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19044933/image-146-300x271.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19044933/image-146-768x693.png 768w" sizes="(max-width: 927px) 100vw, 927px" /></a></figure>
<h3 class="wp-block-heading">Ross Stores</h3>
<ul>
<li>The Trade: Ross Stores, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) Group President, COO Michael J. Hartshorn <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 8,366 shares</a> at an average price of $155.64. The insider received around $1.3 million from selling those shares.</li>
<li>What's Happening: On Aug. 22, Ross Stores reported better-than-expected second-quarter financial results and raised its FY24 EPS guidance with its midpoint above estimates.</li>
<li>What Ross Stores Does: Ross Stores operates as an off-price apparel and accessories retailer with the majority of its sales derived from its Ross Dress for Less banner. </li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1">breakout in ROST</a> shares. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="875" height="841" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19045018/image-147.png" alt="" class="wp-image-555619" style="width:630px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19045018/image-147.png 875w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19045018/image-147-300x288.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19045018/image-147-768x738.png 768w" sizes="(max-width: 875px) 100vw, 875px" /></a></figure>
<h3 class="wp-block-heading">McDonald&#8217;s</h3>
<ul>
<li>The Trade: McDonald&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) Chairman and CEO Christopher J Kempczinski <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 3,934 shares</a> at an average price of $300.00. The insider received around $1.2 million from selling those shares.</li>
<li>What's Happening: On Sept. 16, JP Morgan analyst John Ivankoe maintained McDonald&#8217;s with an Overweight and raised the price target from $270 to $290.</li>
<li></li>
<li>What McDonald&#8217;s Does: McDonald&#8217;s is the largest restaurant owner-operator in the world, with 2023 system sales of $130 billion across nearly than 42,000 stores and 115 markets. </li>
<li>Benzinga Pro's earnings calendar was used to track upcoming <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1">MCD&#8217;s earnings repor</a>ts. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="860" height="813" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19045124/image-148.png" alt="" class="wp-image-555620" style="width:601px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19045124/image-148.png 860w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19045124/image-148-300x284.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19045124/image-148-768x726.png 768w" sizes="(max-width: 860px) 100vw, 860px" /></a></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40925678/fedex-gears-up-for-q1-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-an">FedEx Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>

Insider Trades

ROST

Alphabet, McDonald's And 2 Other Stocks Executives Are Selling

COUR

Coursera shares are trading higher are trading higher after B of A Securities initiated coverage on the stock with a Buy rating and announced an $11 price target.

Ahead of the 2024 election, Kamala Harris and Oprah Winfrey are set to host a virtual event aimed at rallying support in key battleground states.
What Happened: Harris and Winfrey will join forces for an online event on Thursday aimed at rallying support in key battleground states, according to Reuters on Thursday.
The &#8220;Unite for America&#8221; event, co-hosted by Winfrey and the activist group &#8220;Win with Black Women,&#8221; seeks to register voters and bolster Harris&#8217;s campaign in states like Pennsylvania, Georgia, and Michigan. The event will be live-streamed at 8 p.m. EDT (0000 GMT) on social media platforms including Instagram and TikTok.
On the same day, Donald Trump will attend a Washington event on fighting antisemitism and address the Israeli-American Council Summit.
Harris has been campaigning in Michigan, specifically in the Detroit area, local press reported. Numerous grassroots organizations, such as &#8220;Latinas for Harris,&#8221; &#8220;Win With Black Men,&#8221; and &#8220;Republicans for Harris,&#8221; are participating in the event. Win with Black Women focuses on helping Black women win elected offices.
Since Harris entered the race in July, these groups have raised over $20 million for her campaign, according to a press release from Unite for America. Winfrey emphasized the importance of voter motivation and planning in a statement.
See Also: <a href="https://www.benzinga.com/general/politics/24/09/40910999/trump-in-trouble-vice-president-harris-has-record-6-point-lead-in-2024-election-poll-after-debat?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump In Trouble: Vice President Harris Has Record 6-Point Lead In 2024 Election Poll After Debate, Posts Highest Rankings In Key Demographics</a>
According to a recent Reuters poll, Harris leads her Republican opponent Donald Trump 47% to 42%. Harris is ahead in battleground states like Michigan, Pennsylvania, and Wisconsin, while Trump has more support in Georgia.
Why It Matters: Harris&#8217;s campaign has seen significant momentum recently. A recent survey of fund managers, strategists, and economists revealed that <a href="https://www.benzinga.com/news/24/09/40913930/kamala-harris-moves-from-13-point-deficit-to-7-point-lead-over-trump-in-survey-of-fund-managers-stra">Harris had moved from a 13-point deficit</a> to a 7-point lead over Trump. The survey, conducted by CNBC, showed Harris as the likely winner of the November election, with 48% support compared to Trump&#8217;s 41%. This shift in support came after Harris replaced President Joe Biden on the Democratic ticket in July.
Additionally, Harris received a rare endorsement from the <a href="https://www.benzinga.com/general/politics/24/09/40907893/kamala-harris-wins-second-endorsement-in-179-years-from-magazine-that-featured-works-from-nikola">oldest continuously published magazine </a>in the U.S., which has featured works from notable figures like Nikola Tesla and Albert Einstein. This endorsement is significant given the tight contest between Harris and Trump. 
Moreover, pop star Taylor Swift&#8217;s <a href="https://www.benzinga.com/general/entertainment/24/09/40824581/taylor-swifts-endorsement-of-kamala-harris-drives-over-330k-visitors-to-vote-gov">endorsement of Harris</a> drove over 330,000 visitors to vote.gov, highlighting the impact of celebrity endorsements on voter engagement. This surge occurred less than 24 hours after Swift&#8217;s endorsement following the debate between Harris and Trump.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40911991/hillary-clinton-compares-melania-trump-to-the-little-kid-at-a-birthday-party-who-doesnt-know-anyone?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Hillary Clinton Compares Melania Trump To &#8216;The Little Kid At A Birthday Party Who Doesn&#8217;t Know Anyone&#8217; In Her Latest Book</a></li>
</ul>
Image via Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

Politics

Kamala Harris And Oprah Winfrey To Host Virtual Event To Sway Support From Key Battleground States Of Pennsylvania, Georgia And Michigan As Trump Attends Washington Event

Neuraspace's Space Traffic Management (STM) platform provides cutting edge Artificial Intelligence (AI) and Machine Learning (ML) features that reinforce mission safety, efficiency and longevity for Sidus Space.
Sidus Space (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIDU#NASDAQ">SIDU</a>) (the "Company" or "Sidus"), a provider of end-to-end precision Space Infrastructure solutions and Data-as-a-Service products, announced today, at the <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwsbw.com%2F&amp;esheet=54124388&amp;newsitemid=20240919680196&amp;lan=en-US&amp;anchor=World+Space+Business+Week&amp;index=1&amp;md5=537ec7d1903b5bc087101aa73f3d3d2d">World Space Business Week</a> (WSBW) conference in Paris, the signing of an agreement with Neuraspace. Under the agreement, Neuraspace will provide Space Traffic Management and LEOP (Launch and Early Operations) support services to Sidus Space, thereby enhancing the Company's constellation operation capabilities.

SIDU

Sidus Space Enhances LizzieSat Constellation Operations Via Agreement With Neuraspace

At today's event, Thermo Fisher Scientific highlighted:
<ul>
<li>Incredibly well-positioned industry leadership, with leading businesses that enable our customers' success
<ul>
<li>Our industry-leading businesses are benefited by total company scale and capabilities. &nbsp;</li>
</ul>
</li>
<li>Attractive end markets that are fueled by enduring long-term trends
<ul>
<li>Thermo Fisher is the industry leader serving an attractive $235 billion market with long-term market growth of 4% to 6%. &nbsp;</li>
</ul>
</li>
<li>Proven growth strategy drives share gain
<ul>
<li>High-impact innovation: enabling major scientific breakthroughs.</li>
<li>The trusted partner to our customers: enabling customer success with an excellent reputation and credibility built over a long period of time.</li>
<li>Unparalleled commercial engine: commercial advantage through deep engagement with customers wherever they are. &nbsp;</li>
</ul>
</li>
<li>Practical Process Improvement Business System (PPI) enables outstanding execution
<ul>
<li>PPI is the core of Thermo Fisher's culture, with a focus on continuous improvement that drives quality, productivity and customer allegiance and engages every colleague to find a better way, every day.</li>
<li>PPI delivers competitive advantage and drives differentiated financial performance. &nbsp;</li>
</ul>
</li>
<li>Delivering differentiated value creation for all our stakeholders
<ul>
<li>Industry leading businesses have a long-standing track record of value creation.</li>
<li>Disciplined approach to capital deployment, which consists of strategic M&amp;A and returning capital to shareholders, enables us to better serve our customers and create tremendous value for our shareholders.</li>
<li>Mission-led comprehensive CSR strategy delivers competitive advantage through our innovations for a cleaner planet, investments in colleagues and communities and our focus on impact and accountability. More details can be found in the most recent <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcorporate.thermofisher.com%2Fcontent%2Fdam%2Ftfcorpsite%2Fdocuments%2Fcorporate-social-responsibility%2Fannual-reports%2F2023-CSR-Report.pdf&amp;esheet=54124207&amp;newsitemid=20240919299545&amp;lan=en-US&amp;anchor=CSR+Report&amp;index=1&amp;md5=043c86c39168bf774d5a27615ad0617f">CSR Report</a>. &nbsp;</li>
</ul>
</li>
<li>Outstanding track record of financial performance and an excellent long-term outlook
<ul>
<li>Thermo Fisher's proven growth strategy drives share gain, and its capital deployment approach creates tremendous value, positioning the company to deliver organic revenue growth of 7% to 9% and mid-teens adjusted EPS growth over the long term.</li>
</ul>
</li>
</ul>

Thermo Fisher Scientific Hosts 2024 Investor Day, Showcasing Industry-Leading Businesses, Proven Growth Strategy, And Strong Long-Term Financial Outlook

Guidance

Union Pacific Sees Annual Capital Investments Of Roughly $3.5B-$3.7B Over Next Three Years

AmpliTech Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMPG#NASDAQ">AMPG</a>, AMPGW)))), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced receipt of the single cash payment, in excess of $700K, for the reported end of August single sale transaction by its Spectrum Semiconductor Materials Division, this, while AmpliTech Group also surpassing bookings in excess of $1M in the timeframe of September to date, once again as result of increased quoting activity experienced since the start of Q3 2024. &nbsp;
AmpliTech Group is very pleased to see the level of activity in bookings and cash receipts being achieved quarter to date. As recently announced, the company also reported its AGTGSS Division initial contribution to sales for the year with an exciting hardware only sale of some of their private 5G portfolio of products. The company is actively participating in full end-to-end 5G deployment opportunities and believes to be announcing additional exciting projects before the end of the year.

Contracts

AMPG

AmpliTech Group Receives Over $700K In Cash From Single Products Sale At Their Spectrum Division; AmpliTech Group Surpassing Bookings In Excess Of $1M In The Timeframe Of September To Date, As Result Of Increased Quoting Activity Experienced Since The Start Of Q3 2024

Buybacks

Union Pacific Sees Revenue Excluding Fuel Surcharge Revenue To Grow Faster Than Volume Excluding Coal Over Next 3 Years; Union Pacific Sees Annual Share Repurchases Of $4B-$5B Over Next Three Years Starting In 2025

Sen. JD Vance, Donald Trump&#8217;s running mate for the 2024 Presidential Election, has been promoting unverified rumors about Haitian immigrants eating pets, causing unease among GOP lawmakers.
What Happened: Republican lawmakers expressed their discomfort of Vance&#8217;s statements, Business Insider<a href="https://www.businessinsider.in/politics/world/news/some-gop-lawmakers-are-tired-of-jd-vances-cat-rumors/articleshow/113491247.cms"> reported</a> on Thursday.
Rep. Juan Ciscomani (R-Ariz.) criticized the Biden-Harris administration&#8217;s border policies but avoided engaging in the pet-eating claims.
&#8220;I think that conversation, overall, has been distracting from the real issue at hand,&#8221; he said.
Rep. Mike Lawler (R-N.Y.) representing a New York district with a significant Haitian community, emphasized the importance of focusing on larger issues and respecting the Haitian community.
Despite the backlash, Vance defended his actions, claiming the rumors draw attention to American suffering. 
Springfield, Ohio, has seen an influx of Haitian immigrants, which has strained local services but also revitalized the economy. A YouGov poll revealed that 54% of Americans believe the pet-eating claims are false or likely false.
See Also: <a href="https://www.benzinga.com/news/24/09/40911991/hillary-clinton-compares-melania-trump-to-the-little-kid-at-a-birthday-party-who-doesnt-know-anyone?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Hillary Clinton Compares Melania Trump To &#8216;The Little Kid At A Birthday Party Who Doesn&#8217;t Know Anyone&#8217; In</a>
Sen. Mitt Romney (R-Utah) criticized the false claims, stating they harm Haitian refugees. Other Republicans, like Rep. Marc Molinaro, sidestepped questions about the rumors, focusing instead on broader immigration issues.
Why It Matters: The controversy surrounding Vance&#8217;s claims is not occurring in isolation. Trump <a href="https://www.benzinga.com/news/24/09/40807202/trump-says-immigrants-are-eating-the-dogs-in-ohio-during-debate-with-kamala-harris-gets-called-out">reiterated similar allegations</a> during a televised debate with Vice President Kamala Harris on September 10, 2024. Trump claimed that immigrants in Springfield, Ohio, were abducting and consuming pets, which Harris dismissed as &#8220;extreme&#8221; and city officials denied.
Additionally, in August, <a href="https://www.benzinga.com/real-estate/24/08/40303701/jd-vance-blames-20-million-migrants-for-housing-crisis-economists-say-hes-missing-the-point">Vance blamed 20 million migrants</a> for the housing crisis, a stance that economists criticized as missing the point. This context shows a pattern of using immigration as a focal point for broader societal issues.
During the same debate, Trump was also noted for being stuck in a loop of discussing drugs, murders, and illegal immigrants, blaming them for various societal problems. He claimed that migrants were &#8220;destroying our country,&#8221; despite a sharp drop in migration at the U.S.-Mexico border following President Biden&#8217;s June mandate limiting border crossings.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40899012/elon-musk-reacts-after-trump-campaign-releases-over-50-examples-of-democrats-rhetoric-that-inspired?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Reacts After Trump Campaign Releases Over 50 Examples of Democrats&#8217; Rhetoric That &#8216;Inspired Assassination Attempt&#8217;</a></li>
</ul>
Image via Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

JD Vance's Unverified Rumors About Haitian Immigrants Stir GOP Discomfort: 'Distracting From Real Issues At Hand'

ADIL

Adial Pharmaceuticals Announces Database Lock In Pharmacokinetics Study Of AD04 For Alcohol Use Disorder; Topline Results Expected In Q4 2024

AS-IP Tech

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

AS-IP Tech

AS-IP Tech (IPTK) Forecast

AS-IP Tech (OTC:IPTK) Stock, Quote.Headers.trade-ideas